List of insiders holdings for ARS Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Flynn James E Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Director by deputization Director 10% Owner | 2022-11-18 17:06:38 | 11,077,927 0 | 11,077,927 | Form 13D |
Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 2024-03-26 18:48:19 | 4,126,822 6,921,847 | 11,048,669 | Form 4 |
Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 2024-03-26 18:47:24 | 3,276,854 7,771,815 | 11,048,669 | Form 4 |
RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2024-03-27 19:37:52 | 0 10,860,977 | 10,860,977 | Form 4 |
Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner | 2022-11-18 14:17:30 | 10,156,204 0 | 10,156,204 | Form 13D |
ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 2023-08-31 17:26:17 | 0 9,240,887 | 9,240,887 | Form 4 |
Thompson Peter A. Director | 2023-08-31 17:18:44 | 0 9,240,887 | 9,240,887 | Form 4 |
Schroeder Thilo Director | 2020-12-08 20:48:12 | 0 1,910,029 | 1,910,029 | Form 4 |
Alexandria Venture Investments LLC 10% Owner | 2020-12-08 16:36:52 | 699,412 0 | 699,412 | Form 4 |
Pepe Jeffrey C. Interim CEO and GC | 2022-09-08 17:04:48 | 427,750 0 | 427,750 | Form 3 |
Dorsey Brian Chief Operating Officer | 2024-01-04 16:42:31 | 350,000 0 | 350,000 | Form 4 |
Chakma Justin Chief Business Officer | 2024-01-04 16:41:27 | 350,000 0 | 350,000 | Form 4 |
Fitzpatrick Alexander A Chief Legal Officer | 2024-01-04 16:38:57 | 300,000 0 | 300,000 | Form 4 |
Shawver Laura Director | 2023-09-05 20:04:41 | 265,581 0 | 265,581 | Form 4 |
Karas Eric Chief Commercial Officer | 2024-01-04 16:47:38 | 200,000 0 | 200,000 | Form 4 |
Scott Kathleen D. Chief Financial Officer | 2024-01-04 16:39:59 | 200,000 0 | 200,000 | Form 4 |
Piazza Jonathan Chief Financial Officer | 2022-05-04 17:16:04 | 156,608 0 | 156,608 | Form 4 |
Odegard Valerie President and CSO | 2022-05-04 17:12:32 | 152,106 0 | 152,106 | Form 4 |
Hunder Naomi Chief Medical Officer | 2022-05-04 17:07:01 | 140,782 0 | 140,782 | Form 4 |
Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner | 2022-01-27 15:05:08 | 110,120 0 | 110,120 | Form 13D |
Hawkinson Russ Sr. Vice President of Finance | 2022-05-04 17:00:02 | 93,921 0 | 93,921 | Form 4 |
Dadoo Rajeev Director | 2023-06-28 21:03:55 | 40,000 0 | 40,000 | Form 4 |
Kelly Michael Director | 2023-06-28 21:00:49 | 40,000 0 | 40,000 | Form 4 |
Shah Pratik Director 10% Owner | 2023-06-28 21:00:44 | 40,000 0 | 40,000 | Form 4 |
SAUNDERS BRENT L Director | 2023-06-28 21:00:29 | 40,000 0 | 40,000 | Form 4 |
SCHNEIDER PHILLIP M Director | 2023-06-28 21:00:18 | 40,000 0 | 40,000 | Form 4 |
Islam Saqib Director | 2023-06-28 21:00:13 | 40,000 0 | 40,000 | Form 4 |
Koehler Maria Director | 2022-06-13 19:39:13 | 18,000 0 | 18,000 | Form 4 |
CAPPS VICKIE L Director | 2022-06-13 19:27:09 | 18,000 0 | 18,000 | Form 4 |
HERSHBERG ROBERT Director | 2022-06-13 19:31:19 | 18,000 0 | 18,000 | Form 4 |
ROOT JONATHAN D Director | 2022-06-13 19:48:06 | 18,000 0 | 18,000 | Form 4 |
Powell Andrew Kenneth William Director | 2022-06-13 19:44:15 | 18,000 0 | 18,000 | Form 4 |
LEFF JONATHAN S Director | 2022-11-10 17:00:26 | 0 0 | 0 | Form 3 |